Studying blood markers in diabetic kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at simple blood tests to see if certain markers of inflammation and platelet levels are different in people with diabetic kidney disease compared to healthy people. The results might help doctors find kidney problems earlier in people with type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have type 2 diabetes (or be a healthy person of similar age and sex for comparison).
- You cannot have type 1 diabetes or any kidney disease not caused by diabetes.
- You must not have an active infection or signs of inflammation right now.
- You cannot have a history of cancer, autoimmune diseases (like lupus or rheumatoid arthritis), or chronic liver disease.
- You must not be pregnant or have had recent treatment with steroids or immune-suppressing drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to find early signs of kidney damage in people with diabetes. The goal is to catch kidney disease (diabetic nephropathy) sooner, so it can be managed more effectively.
This study looks at how common diabetic kidney damage is in people with type 2 diabetes, and which factors can predict it. If you qualify, you may be asked to have a kidney biopsy to understand what’s happening inside your kidneys.
This study looks at how the bacteria in your gut and certain blood markers might help predict changes in blood sugar levels for people with type 2 diabetes and kidney disease. The findings could lead to better ways to manage your condition and prevent complications.
This study looks at people with type 2 diabetes who have kidney problems and relates their symptoms and lab findings to what is seen on kidney biopsy. It may help doctors better understand what is driving kidney damage in diabetes.
This trial looks at two proteins in your blood (cathepsin S and chromogranin A) to see if they can help detect early kidney damage in people with type 2 diabetes. If they are useful, doctors might be able to find kidney problems earlier and start treatment sooner.
This study collects and studies kidney tissue (from a biopsy or surgery) from people with diabetes-related kidney disease to learn more about the condition. You may be able to help if you've already had a kidney biopsy or certain kidney surgeries.
Hear when a new Diabetic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.